Rapid NGS For Genomic Profiling In Myeloid Malignancies Research

Association for Molecular Pathology (AMP) 2023 Corporate Workshop

 

 

The future of molecular profiling requires fast turnaround time for an increasingly large number of genetic biomarkers. Rapid next-generation sequencing (NGS) is helping to accelerate these critical insights by enabling test results to be available in as little as a single day.

During this workshop, see how rapid NGS is helping to facilitate swift patient enrollment into a clinical trial aiming to investigate the effectiveness of various therapeutic agents based on genetic testing results. Also, learn how NGS technology is advancing measurable residual disease (MRD) analysis by detecting low-frequency variants with high sensitivity across a broad number of genes simultaneously.


Presenters

 

Cecilia Yeung, MD.
Associate Professor, Clinical Research Division
Fred Hutchinson Cancer Center
Medical Director, Fred Hutch CLIA Laboratories

Lauren Frady, MS, MB(ASCP)
Staff Scientist, Assay Development
Q2 Solutions

Get In Touch

 

Request a quote or personal demonstration of our NGS solutions from a Thermo Fisher Representative.

Request Contact

For Research Use only. Not for use in diagnostic procedures.
Case number: 52968
04/24

Style Sheet for Global Design System